Marshall Urist, EVP & Co-Head Research & Inv at Royalty Pharma plc (RPRX), sold 2,000 shares at $41.08 ($82K) on 2021-05-20, disclosed to the SEC on 2021-05-24.
Open-market sale of $82k RPRX by EVP & Co-Head Research & Inv. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.08 | 1,900 | $78K | 95.0% |
| 2 | $41.00 | 100 | $4K | 5.0% |
| Total | $41.08 avg | 2,000 | $82K | 100% |
| Filing → |
| RPRX | SELL | 2026-07-02 | $508K | — | Filing → |
| RPRX | SELL | 2026-06-25 | $502K | — | Filing → |
| RPRX | SELL | 2026-05-21 | $722K | — | Filing → |